DrugDashboards

Dapagliflozin

Dapagliflozin · DAPAGLIFLOZIN 10 mg/1 · Tablet, Film Coated · Oral · Novadoz Pharmaceuticals LLC

NDC 72205-0433-01 · 30 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

20 companies supply this market — deep enough that no single failure threatens the supply. The brand (Farxiga) runs $12.08 per unit — 62× more. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.2049per EAinvoice-surveyed acquisition cost · Jun 3, 2026
  • Part D plans paid (avg)$16.24per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.6920per TABweighted avg manufacturer price $0.3954 · Aug 1, 2026338% of what pharmacies pay — higher than 95% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.25$0.5$0.75Jun 2026Sep 2026$0.2049
1 price point · per EA · held since Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$6.15
#90 count
$18.44

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for dapagliflozin (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA211478
TE code
AB
Approval date
Apr 6, 2026
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dapagliflozin (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsDAPAGLIFLOZIN PROPANEDIOL 10 mg/1Jul 15, 2026Sep 3, 2026
AstraZeneca Pharmaceuticals LPDAPAGLIFLOZIN PROPANEDIOL 5 mg/1Jul 15, 2026Sep 3, 2026
AstraZeneca Pharmaceuticals LPDAPAGLIFLOZIN PROPANEDIOL 10 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsDAPAGLIFLOZIN 5 mg/1Jul 15, 2026Sep 2, 2026
A-S Medication SolutionsDAPAGLIFLOZIN 10 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DAPAGLIFLOZIN 5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.DAPAGLIFLOZIN 10 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDAPAGLIFLOZIN 5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDAPAGLIFLOZIN 10 mg/1Jul 15, 2026Sep 2, 2026
ANI Pharmaceuticals, Inc.DAPAGLIFLOZIN 10 mg/1Jul 15, 2026Sep 2, 2026
ANI Pharmaceuticals, Inc.DAPAGLIFLOZIN 5 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.DAPAGLIFLOZIN 10 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.DAPAGLIFLOZIN 5 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCDAPAGLIFLOZIN 10 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCDAPAGLIFLOZIN 5 mg/1Jul 15, 2026Sep 2, 2026
AstraZeneca ABDAPAGLIFLOZIN PROPANEDIOL 5 mg/1Jul 15, 2026Sep 2, 2026
AstraZeneca ABDAPAGLIFLOZIN PROPANEDIOL 10 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedDAPAGLIFLOZIN 5 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedDAPAGLIFLOZIN 10 mg/1Jul 15, 2026Sep 2, 2026
AvKAREDAPAGLIFLOZIN 5 mg/1Jul 15, 2026Sep 2, 2026
AvKAREDAPAGLIFLOZIN 10 mg/1Jul 15, 2026Sep 2, 2026
Biocon Pharma Inc.DAPAGLIFLOZIN 2,3-BUTANEDIOL MONOHYDRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Biocon Pharma Inc.DAPAGLIFLOZIN 2,3-BUTANEDIOL MONOHYDRATE 10 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackDAPAGLIFLOZIN PROPANEDIOL 10 mg/1Jul 15, 2026Sep 2, 2026
Cipla USA Inc.DAPAGLIFLOZIN PROPANEDIOL 10 mg/1Jul 15, 2026Sep 2, 2026
Cipla USA Inc.DAPAGLIFLOZIN PROPANEDIOL 5 mg/1Jul 15, 2026Sep 2, 2026
IPR Pharmaceuticals, IncDAPAGLIFLOZIN PROPANEDIOL 5 mg/1Jul 15, 2026Sep 2, 2026
IPR Pharmaceuticals, IncDAPAGLIFLOZIN PROPANEDIOL 10 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCDAPAGLIFLOZIN 5 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCDAPAGLIFLOZIN 10 mg/1Jul 15, 2026Sep 2, 2026
Prasco LaboratoriesDAPAGLIFLOZIN PROPANEDIOL 10 mg/1Jul 15, 2026Sep 2, 2026
Prasco LaboratoriesDAPAGLIFLOZIN PROPANEDIOL 5 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.DAPAGLIFLOZIN PROPANEDIOL 5 mg/1Jul 15, 2026Sep 2, 2026
Sandoz IncDAPAGLIFLOZIN 10 mg/1Jul 15, 2026Sep 2, 2026
Sandoz IncDAPAGLIFLOZIN 5 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.DAPAGLIFLOZIN 5 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.DAPAGLIFLOZIN 10 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals, Inc.DAPAGLIFLOZIN 10 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals, Inc.DAPAGLIFLOZIN 5 mg/1Jul 15, 2026Sep 2, 2026
A-S Medication SolutionsDAPAGLIFLOZIN PROPANEDIOL 5 mg/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dapagliflozin — NDC 72205-0433-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72205043301.

Free to cite with attribution — see how the data is put together.